Relationship between CYP1A1 genetic polymorphisms and renal cancer in China

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2163-2166

  Chen, Junxiang ^a   Cheng, Meichu ^a   Li, Yi ^a   Jiang, Chang Bin ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

China; CYP1A1; Genetic polymorphism; Renal cell cancer

Indexed keywords

CYP1A1 PROTEIN, HUMAN; CYTOCHROME P450 1A1;

ALLELE; ARTICLE; ASIAN; CASE CONTROL STUDY; CHINA; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; RISK FACTOR; SMOKING; STATISTICAL MODEL;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CHINA; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 84866265255     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. International Agency for Research on Cancer (2008). Cancer Incidence and Mortality Worldwide in 2008. http://globocan.iarc.fr/.
2. Ferlay J, Bray F, Pisani P, et al (2004). GLOBOCAN 2002: cancer incidence, mortality, and prevalence worldwide. Lyon, IARC Press.
3. Greenlee RT, Hill-Harmon MB, Murray T, et al (2001). Cancer statistics, 2001. CA Cancer J Clin, 51, 15-36.
4. Hayashi S, Watanabe J, Nakachi K, et al (1991). Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem, 110, 407-11.
5. Hildebrandt AG, Schwarz D, Krusekopf S, et al (2007). Recalling P446. P4501A1 (CYP1A1) opting for clinical application. Drug Metab Rev, 39, 323-41.
6. Hollingsworth JM, Miller DC, Daignault S, et al (2006). Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst, 98, 1331-1334.
7. Kawajiri K (1999). Cyp1a1. IARC Sci Publ, 148, 159-72.
8. Kawajiri K, Eguchi H, Nakachi K, et al (1996). Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res, 56, 72-6.
9. Kawajiri K, Nakachi K, Imai K, et al (1993). The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol, 14, 77-87.
10. Kruys V, Wathelet M, Poupart P, et al (1987). The 3' untranslated region of the human interferon-beta mRNA has an inhibitory effect on translation. Proc Natl Acad Sci USA, 84, 6030-4.
11. Levy JR, Hannah S, Mooney RL, et al (1995). Sequence and functional characterization of the terminal exon of the human insulin receptor gene. Biochim Biophys Acta, 1263, 253-7.
12. Mathew A, Devesa SS, Fraumeni JF Jr, et al (2002). Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev, 11, 171-8.
13. Nakachi K, Imai K, Hayashi S, et al (1993). Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res, 53, 2994-9.
14. Schwarz D, Kisselev P, Schunck WH, et al (2000). Allelic variants of human cytochrome P450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity. Pharmacogenetics, 10, 519-30.
15. Shaik AP, Jamil K, Das P (2009). CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Urol J, 6, 78-86.
16. Sivaraman L, Leatham MP, Yee J, et al (1994). CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res, 54, 3692-5.
17. Smith G, Stubbins MJ, Harries LW, et al (1998). Molecular genetics of the human cytochrome P450 monooxygenase superfamily. Xenobiotica, 28, 1129-95.
18. Smits KM, Schouten LJ, van Dijk BA, et al (2008). Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancer. World J Urol, 26, 103-10.
19. Tanguay RL, Gallie DR (1996). Translational efficiency is regulated by the length of the 3' untranslated region. Mol Cell Biol, 16, 146-56.
20. Wang GP, Zhang P, Xu M, et al (2008). Association of genetic polymorphisms in CYP1A1 and NAT2 with susceptibility to renal cancer: a case control study. Academic Journal of Second Military Medical University, 29, 1147-52.
21. Weikert S, Ljungberg B (2010). Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol, 28, 247-52.
22. Zhuo W, Wang Y, Zhuo X, et al (2009). CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses. Cancer Invest, 27, 86-95.